Dr. Ryan Pickens

Dr. Ryan Pickens
Dr. Pickens was born and raised in Murray, Kentucky. He received his medical degree from the University of Louisville College of Medicine. He completed his internship in general surgery and urologic training at the University of Tennessee Medical Center in Knoxville, Tennessee. He then completed a two-year urologic fellowship in Endourology and Minimally Invasive Surgery at Vanderbilt University Medical Center in Nashville, Tennessee. Dr. Pickens is also trained in minimally invasive surgery (laparoscopic and robotic) for the treatment of benign and malignant urologic diseases. He performs robotic pyeloplasties for UPJ obstruction as well as robotic ureteral reimplants and Boari Flaps for ureteral stricture disease. He is very involved with the University of Tennessee Transplant Program and performs laparoscopic nephrectomies for those wishing to donate their kidney. Dr. Pickens’ main interests are in the surgical and medical management of kidney stone disease and BPH. Dr. Pickens performs the region's largest number of PCNLs for large kidney stones and a national leader in the newest procedure mini PCNL for medium to large kidney stones. For large prostates he performs Holmium Laser Enucleation of the Prostate (HoLEP) and Robotic Simple Prostatectomy. He is also trained in minimally invasive surgery (laparoscopic and robotic) for the treatment of benign and malignant urologic diseases.
Medical School:

University of Louisville


University of Tennessee-Knoxville


Vanderbilt University


University of Kentucky

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only